A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma

Aberrant expression and activation of signal transducer and activator of transcription 3 (STAT3) is implicated in several malignancies, including glioblastoma, and is correlated with poor outcomes in patients with glioblastoma, rendering STAT3 a potential therapeutic target. However, few STAT3 inhib...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Li, Zhaoqing, Zhu, Tingting, Xu, Yini, Wu, Chuanqiang, Chen, Jinliang, Ren, Yu, Kong, Lingping, Sun, Shanshan, Guo, Wenyu, Wang, Yu, Jing, Chao, Dong, Jiabin, Zhou, Jia, Zhang, Lun, Shen, Qiang, Zhou, Xuan
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511646/
https://ncbi.nlm.nih.gov/pubmed/31105997
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars